A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS
The original article tells about the key aspects that characterize the problem of acute coronary syndrome without ST-segment elevation (ACSWSTE) in the Russian Federation: high prevalence, current approaches to risk assessment of early and long-term adverse outcomes and diagnostic challenges. Based...
Main Authors: | O. L. Barbarash, V. V. Kashtalap |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1766 |
Similar Items
-
Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study
by: Tapan Mehta, et al.
Published: (2023-01-01) -
Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01) -
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
by: Marc P. Bonaca, et al.
Published: (2018-11-01) -
Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01) -
Differential impact of fentanyl and morphine doses on ticagrelor-induced platelet inhibition in ST-segment elevation myocardial infarction: a subgroup analysis from the PERSEUS randomized trial
by: Dorian Garin, et al.
Published: (2024-04-01)